Dave director trust sells 64,991 warrants

A Dave Inc. director’s trust sold 64,991 warrants in three September 2026 open-market transactions at weighted average prices near $1.60.

Rhea-AI Filing Summary

Dave Inc. (DAVE) director Brendan Carroll reported three indirect sales of warrants (rights to buy Class A Common Stock) held by a trust. The trust sold 64,991 warrants in total on September 10, 11, and 14, 2026 at reported weighted average prices around $1.59–$1.60 per warrant. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Seller: 64,991 shares

Net Sell 3 txns

Insider Carroll Brendan

Role Director

Sold 64,991 shs ($104K)

Type	Security	Shares	Price	Value
Sale	Warrant (Right to Buy) F3	33,453	$1.60	$54K
Sale	Warrant (Right to Buy) F2	16,179	$1.59	$26K
Sale	Warrant (Right to Buy) F1	15,359	$1.59	$24K

Holdings After Transaction: Warrant (Right to Buy) — 44,994 contracts (Indirect, By Trust)

Footnotes (3)

1. F1. The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $1.56 to $1.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the range set forth in this Form 4.
2. F2. The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $1.58 to $1.62, inclusive.
3. F3. The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $1.56 to $1.70, inclusive.

Key Figures

Total warrants sold: 64,991 warrants Warrants sold on September 10, 2026: 15,359 warrants Warrants sold on September 11, 2026: 16,179 warrants +4 more

7 metrics

Total warrants sold 64,991 warrants Aggregate of three warrant sale transactions reported for September 10–14, 2026

Warrants sold on September 10, 2026 15,359 warrants Open-market or private sale at a weighted average price of $1.59

Warrants sold on September 11, 2026 16,179 warrants Open-market or private sale at a weighted average price of $1.59

Warrants sold on September 14, 2026 33,453 warrants Open-market or private sale at a weighted average price of $1.60

Exercise price per underlying share $368.00 Conversion or exercise price of each warrant into Class A Common Stock

Underlying shares per transaction 480; 506; 1,045 shares Underlying Class A Common Stock tied to the September 10, 11, and 14, 2026 warrant sales

Warrant expiration date January 5, 2027 Expiration date for the reported warrants

Key Terms

Warrant (Right to Buy), weighted average price, Class A Common Stock, Rule 10b5-1

4 terms

Warrant (Right to Buy) financial

"security titled "Warrant (Right to Buy)" linked to Class A Common Stock"

weighted average price financial

"The price reported in Column 8 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Class A Common Stock financial

"underlying security title is Class A Common Stock for each warrant"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these transactions"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did DAVE report for director Brendan Carroll?

The filing reports that a trust associated with director Brendan Carroll sold a total of 64,991 warrants to purchase Dave Inc. Class A Common Stock in three open-market transactions on September 10, 11 and 14, 2026.

What prices were the DAVE warrants sold for in these Form 4 transactions?

Reported prices are weighted averages. On September 10, 2026 the average was $1.59 with trades from $1.56–$1.60; on September 11, $1.59 with trades from $1.58–$1.62; on September 14, $1.60 with trades from $1.56–$1.70.

How many DAVE warrants were sold in each of Brendan Carroll’s trust transactions?

The trust sold 15,359 warrants on September 10, 2026, 16,179 warrants on September 11, 2026, and 33,453 warrants on September 14, 2026, all reported as open-market or private sale transactions.

What are the terms of the DAVE warrants involved in these Form 4 sales?

Each security is a Warrant (Right to Buy) Dave Inc. Class A Common Stock with a conversion or exercise price of $368.00 per share, an exercise date of March 4, 2022, and an expiration date of January 5, 2027 as reported.

Were Brendan Carroll’s DAVE warrant sales made under a Rule 10b5-1 plan?

No. The filing indicates the Rule 10b5-1 checkbox is not marked, and the footnotes do not state that these warrant sales were made pursuant to a Rule 10b5-1 trading plan.

Are the DAVE warrant holdings reported as directly or indirectly owned by Brendan Carroll?

All three transactions are reported as indirect ownership with the nature of ownership described as “By Trust”, meaning the warrants were held and sold through a trust associated with Brendan Carroll.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 06:00 PM EDT Accepted by SEC EDGAR 09/14/2026 - 06:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carroll Brendan

(Last) (First) (Middle)

1265 SOUTH COCHRAN AVE

(Street)

LOS ANGELES CALIFORNIA 90019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Dave Inc./DE [ DAVE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (Right to Buy)	$368	09/10/2026		S			15,359	03/04/2022	01/05/2027	Class A Common Stock	480	$1.59(1)	94,626	I	By Trust
Warrant (Right to Buy)	$368	09/11/2026		S			16,179	03/04/2022	01/05/2027	Class A Common Stock	506	$1.59(2)	78,447	I	By Trust
Warrant (Right to Buy)	$368	09/14/2026		S			33,453	03/04/2022	01/05/2027	Class A Common Stock	1,045	$1.6(3)	44,994	I	By Trust

Explanation of Responses:

1. The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $1.56 to $1.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the range set forth in this Form 4.

2. The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $1.58 to $1.62, inclusive.

3. The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $1.56 to $1.70, inclusive.

	/s/ Joan Aristei as Attorney-in-Fact for Brendan Carroll	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)